selected Announcements:
Hainan Airlines Holding Co.Ltd(600221) : the actual controller Fang Wei plans to increase the holding of 50 million shares to 100 million shares
E company news, Hainan Airlines Holding Co.Ltd(600221) (600221) announced on February 10 that the company's actual controller Fang Wei plans to increase its shares in the company through the centralized bidding trading system of Shanghai Stock Exchange within six months from February 10, 2022. The number of shares to be increased this time is 50 million to 100 million shares (accounting for about 0.15% to 0.30% of the company's shares). There is no price range for this increase, and the increase will be implemented according to the fluctuation of the company's stock price and the overall trend of the capital market.
Wuxi Apptec Co.Ltd(603259) : the company found no other media reports or market rumors that need clarification or response
E company news, Wuxi Apptec Co.Ltd(603259) (603259) issued an announcement of abnormal stock trading fluctuations on February 10. Neither the company nor its subsidiaries were included in the "unverified list" by the U.S. Department of Commerce. According to the company's self-examination, as of the disclosure date of this announcement, the company has not found any other media reports or market rumors that need to be clarified or responded.
Northeast Pharmaceutical Group Co.Ltd(000597) : the subsidiary fosfomycin ambuterol powder passed the conformity evaluation of generic drugs
E company news, Northeast Pharmaceutical Group Co.Ltd(000597) (000597) announced on February 10 that No. 1 pharmaceutical, a wholly-owned subsidiary of the company, received the notice of approval of drug supplementary application approved and issued by the State Food and drug administration. After review, fosfomycin aminobutanol powder is deemed to have passed the consistency evaluation of quality and efficacy of generic drugs. Fosfomycin tromethamine powder is suitable for the treatment of acute simple urinary tract infection caused by sensitive Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, Citrobacter, Enterobacter and Proteus mirabilis.
Anhui Wanwei Updated High-Tech Material Industry Co.Ltd(600063) : it is proposed to acquire 100% equity of wanwei Wansheng with 795 million yuan
E company news, Anhui Wanwei Updated High-Tech Material Industry Co.Ltd(600063) (600063) announced on February 10 that the company plans to purchase 100% equity of wanwei Changsheng held by the counterparty by issuing shares, and plans to issue shares to wanwei group to raise supporting funds. After negotiation, the price of the issued shares is RMB 3.295 billion, and the price of the issued shares is RMB 3.295 billion. The supporting funds to be raised this time shall not exceed 199 million yuan, and the issue price shall be 4.52 yuan / share. After acquiring wanwei Wansheng, the company realized the vertical extension of PVB resin raw materials to the downstream product line, and became a national leading enterprise covering the whole industrial chain of pva-pvb resin PVB intermediate membrane.
China Fortune Land Development Co.Ltd(600340) : the controlling shareholder Huaxia Holdings has passively reduced 1.11% of its shares
E company news, China Fortune Land Development Co.Ltd(600340) (600340) announced on February 10 that Huaxia holdings, the controlling shareholder of the company, implemented compulsory disposal procedures for the company's shares held by Huaxia holdings due to its stock pledge repo and margin trading business, As a result, the shareholding ratio of Huaxia Holdings has decreased passively from November 30, 2021 to February 10, 2022, reaching 1.11% of the current total share capital of the company. After this equity change, the total shareholding ratio of Huaxia holdings and its concerted actors will be reduced from 23.56% to 22.45%.
Shenzhen Yhlo Biotech Co.Ltd(688575) : covid-19 virus antigen detection kit has been certified by Japan PMDA and supplied
E company, Shenzhen Yhlo Biotech Co.Ltd(688575) (688575) announced in February 10th that the New Coronavirus antigen detection kit of the Japanese Medical Research Institute of the Japanese partner Co., Ltd. (referred to as "MBL") obtained the license for production and sale of external diagnostic products (Japan's PMDA certification) issued by Japan PMDA in February 10th. The company is designated manufacturer of MBL New Coronavirus antigen detection kit. After obtaining the PMDA certification, the product will be sold in Japan, and can be used for medical testing and home self testing.
tianyoude liquor: the controlling shareholder Huashi investment plans to reduce its holding of no more than 2%
E company news, tianyoude liquor (002646) announced on February 10 that the controlling shareholder Huashi investment plans to reduce its holdings of no more than 9451300 shares, accounting for 2% of the total share capital of the company.
Semiconductor Manufacturing International Corporation(688981) : the net profit in the fourth quarter of 2021 increased by 172.7% year-on-year
E company news, Semiconductor Manufacturing International Corporation(688981) (688981) disclosed the performance express of the fourth quarter of 2021 on February 10, realizing a total operating revenue of 10.26 billion yuan, a year-on-year increase of 53.8%, and a net profit of 3.415 billion yuan, a year-on-year increase of 172.7%. Mainly due to the increase of sales revenue due to the increase of wafer sales, the increase of average selling price and the change of product portfolio; And an increase in income from investing in associates and financial assets.
